1 completed, 1 recruiting. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Recruiting 1 |
Follow Immunosuppressive Agents: new trials by email Literature Review of Immunosuppressive Agents trials Research Report on Immunosuppressive Agents
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Eduction in ImmunoSuppressive Regimen Among Kidney Transplant Recipients Patients Admitted to the Intensive Care Unit for Septic Shock and/or Acute Respiratory Failure Hydrocortisone Hemisuccinate: 200 mg per day., reduction of the level of immunosuppression - Sepsis and Septic Shock, Acute Respiratory Failure | Phase 4 | Recruiting | University Hospital, Strasbourg, France | 212 | 2026-08-11 | 2026-08-20 |
| An Open, Single Centre, Randomised, Parallel Group Study to Investigate Three Different Immunosuppressive Regimens Rapamycin, Everolimus, Prednisone - Comparative Study, Immunosuppressive Agents | Phase 4 | Completed | University Hospital, Basel, Switzerland | 63 | 2008-07-01 | 2010-08-17 |
Sepsis (1) · Shock, Septic (1)
Infections (1) · Inflammation (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Shock (1) · Systemic Inflammatory Response Syndrome (1)
Everolimus (1) · Prednisone (1) · Sirolimus (1) · hydrocortisone hemisuccinate (1)
University Hospital, Basel, Switzerland (1) · University Hospital, Strasbourg, France (1)
France (1) · Switzerland (1)